Parkinson's disease : anatomy, pathology, and therapy / editors, Max B. Streifler [and others].

Format:

Book

Conference/Event

Contributor:

Streifler, Max B.

Conference Name:

International Symposium on Parkinson's Disease (9th : 1988 : Jerusalem)

Series:

Advances in neurology ; 0091-3952 v. 53.

Advances in neurology ; v. 53

Language:

English

Subjects (All):

Parkinson's disease--Pathophysiology--Congresses.

Parkinson's disease.

Parkinson's disease--Chemotherapy--Congresses.

Parkinson's disease--Chemotherapy.

Parkinson's disease--Pathophysiology.

Parkinson Disease--pathology.

Parkinson Disease--therapy.

Medical Subjects:

Parkinson Disease--pathology.

Parkinson Disease--therapy.

Genre:

Conference papers and proceedings.

Physical Description:

xxviii, 596 pages : illustrations ; 27 cm.

Place of Publication:

New York : Raven Press, [1990]

Contents:

New developments in the pathology of Parkinson's disease

Nigrostriatal system in Parkinson's disease

Anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability

Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia

Ultrastructure and immunocytochemistry of left and right nigrostriatal system after lesion of right side of substantia nigra of rat

Clinical and pathological features of corticobasal degeneration

Pathological study of the association between Lewy body disease and Alzheimer's disease

Interactions of exogenous L-dopa with nigrostriatal dopaminergic neurons in Parkinson's disease

Recent finding on dopaminergic transmission in the basal ganglia

In vivo studies of striatal dopamine release and metabolism following administration of L-dopa

Efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?

Antiparkinsonian activity of dopamine agonists and their interaction with central dopamine receptor subtypes

Basal ganglia depletion does not alter D1 dopamine receptor binding properties.

Dopaminergic nigropallidal projection in primates: distinct cellular origin and relative sparing in MPTP-treated monkeys

Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia

Neurotrophic factors and Parkinson's disease

Cholinergic muscarinic binding of blood lymphocytes in patients with Parkinson's disease

Brain glucose metabolism in Parkinson's disease

Superoxide dismutase-like activity in the Parkinson's disease brain

Brain substance P receptors in Parkinson's disease

Role of MAO in dopaminergic transmission

Role of iron in the basal ganglion

"Serotonin hypothesis" for depression in Parkinson's disease

Behavior of motor units in parkinsonism

Conditioning transcranial cortical stimulation (TCCS) by exteroceptive stimulation in parkinsonian patients

Kinematic properties of upper-limb trajectories in Parkinson's disease and idiopathic torsion dystonia

Precision grip in parkinsonian patients

Inhibition of ATP synthesis by 1-methyl-4-phenylpyridinium ion (MPP+) in mouse brain in vitro and in vivo.

Age, environments, and number of substantia nigra neurons

Changes of tyrosine hydroxylase in parkinsonian brains and in the brains of MPTP-treated mice

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration

Behavioral and biochemical effects of 4-phenylpyridine, 2-phenylpyridine, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rodents

Interference of 3-0-methyldopa with L-dopa treatment for MPTP-induced parkinsonism in mice

Intracerebroventricular infusion of (+)-4-propyl-9-hydroxy-naphthoxacine in monkeys with MPTP-induced akinesia

Chronic administration of MPTP to marmosets

Research diagnostic criteria for Parkinson's disease

Parkinson's disease beginning before age 40

Muscular weakness in Parkinson's disease

Psychogenic tremors

Cerebrospinal fluid dopamine, norepinephrine, and epinephrine concentrations in Parkinson's disease correlated with clinical symptoms

Diffuse Lewy body disease: the clinical features

Autosomal dominant Lewy-body Parkinson's disease

Progressive supranuclear palsy: motor, neurobehavioral, and neuro-ophthalmic findings

Parkinson's disease and hydrocephalus

Do parkinsonians exhibit visuospatial deficits?

Shifting ability in Parkinson's disease: does shifting ability really deteriorate?

Parkinson's disease and the frontal hypothesis: task alteration in verbal fluency

Aspects of language in parkinsonism

Premorbid personality and idiopathic Parkinson's disease

Premorbid personality of patients with Parkinson's disease: a comparative study with health controls and patients with essential tremor.

Risk factors for dementia in Parkinson's disease

Psychosocial problems of parkinson patients: approaches to assessment and treatment

Parkinson's disease, motoneuron disease and Alzheimer's disease: origins and interrelationship

Electrophysiological features of the dementia of Parkinson's disease

Distinctive aspects of cognitive dysfunction in Parkinson's disease

Motor response complications with chronic levodopa therapy

Clincal experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease

Utilization of antiparkinsonian drugs in Sweden, 1974-1987

Dopaminergic psychosis in advanced Parkinson's disease

Longitudinal study of effects of early levodopa treatment on disability and mortality in Parkinson's disease

Psychiatric complications and shift of death age in parkinson's disease

Parkinson's disease mortality: preliminary report

Early dopamine agonist treatment in Parkinson's disease

Bromocriptine and levodopa in early combination in Parkinson's disease: first results of the collaborative European multicentric trial

Nigrostriatal dopaminergic activity, deprenyl treatment, and longevity

L-deprenyl, a MAO-B inhibitor, as an adjunct to conventional L-dopa therapy in Parkinson's disease: experience in 200 patients

Early combination with deprenyl: a retrospective analysis

Effects of L-deprenyl on parkinsonian bradyphrenia.

Effect of R-(

)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPS, HIAA, aand HVA levels of cerebrospinal fluiid

Beneficial effect of chronic lisuride administration compared with levodopa in Parkinson's disease

Vitamin E therapy in Parkinson's disease

Autonomic nervous system disturbances in Parkinson's disease

Levodopa tretment of Parkinson's syndrome: past and future

Madopar HBS (hydrodynamically balanced system) in the treatment of Parkinson's disease

Inhibitors of dopamine inactivating systems as antiparkinson drugs

Catechol-O-methyltransferase and its role in catecholamine metabolism

Ro 40-7592, a novel, very potent, and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats

Ro 19-6327, a reversible and highly selective monoamine oxidase B inhibitor: a novel tool to explore the MAO-B function in humans

Controlled-release dopamine polymers as a novel approach to the treatment of Parkinson's disease

Long-term treatment with madopar HBS in parkinsonians with fluctuations

Madopar HBS in nocturnal symptoms of Parkinson's disease

Mesulergine: a dopamine agonist with novel properties in Parkinson's disease

Clinical experience with cabergoline, a new ergoline derivative, in the treatment of Parkinson's disease

Clinical benefit of NADH as stimulator of endogenous L-dopa biosynthesis in parkinsonian patients

Effects of transplantation of cross-species substantia nigra into the lateral ventricle of rats with experimentally induced hemiparkinsonism

Adrenal neural transplants in Parkinson's disease

Adrenal medullary transplants as a treatment for Parkinson's disease

Adrenal medullary tissue transplantation in Parkinson's disease: a review.

Notes:

Proceedings from the Ninth International Symposium on Parkinson's Disease, held in Jerusalem, Israel, June 1988.

Includes bibliographical references and index.

Other Format:

Online version: Parkinson's disease.

ISBN:

0881676349

9780881676341

OCLC:

21951133